STOCK TITAN

VistaGen Therapeutics to Participate in William Blair Biotech Focus Conference 2021

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

VistaGen Therapeutics (NASDAQ: VTGN) has announced its participation in the 'Updates in Neuropsych' panel at the William Blair Biotech Focus Conference 2021, scheduled for July 15, 2021, at 9:00 a.m. PT. The event aims to showcase advancements in the treatment of anxiety, depression, and other CNS disorders. VistaGen will also hold one-on-one meetings throughout the virtual conference. Interested parties can access the live webcast on the company’s website.

Positive
  • None.
Negative
  • None.

SOUTH SAN FRANCISCO, Calif., July 09, 2021 (GLOBE NEWSWIRE) -- VistaGen Therapeutics (NASDAQ: VTGN), a biopharmaceutical company committed to developing a new generation of medicines with the potential to go beyond the current standard of care for anxiety, depression, and other central nervous system (“CNS”) disorders, today announced that management will participate in the ‘Updates in Neuropsych’ panel at the virtual William Blair Biotech Focus Conference 2021 on July 15, 2021 at 9:00 a.m. PT. VistaGen will also be participating in one-on-one meetings throughout the conference.

William Blair Biotech Focus Conference 2021  

Panel:Updates in Neuropsych
Date:Thursday, July 15 at 9:00 a.m. PT
Webcast:https://wsw.com/webcast/blair59/panel8/2166208
Registration:To attend the virtual conference, please contact your William Blair representative.

The panel will be held virtually, and a live webcast will be accessible through the News/Events page of the Investors section of the company’s website at www.VistaGen.com.

About VistaGen
VistaGen Therapeutics is a biopharmaceutical company committed to developing and commercializing innovative medicines with the potential to go beyond the current standard of care for anxiety, depression, and other CNS disorders. Each of VistaGen's three drug candidates has a differentiated potential mechanism of action, has been well-tolerated in all clinical studies to date, and has therapeutic potential in multiple CNS markets. For more information, please visit www.VistaGen.com and connect with VistaGen on TwitterLinkedIn, and Facebook.

Company Contacts
Mark A. McPartland / Mark Flather
VistaGen Therapeutics, Inc.
Phone: +1 (650) 577-3606/+1 (650) 577-3617
Email: IR@vistagen.com


FAQ

What is VistaGen Therapeutics' participation in the July 2021 conference?

VistaGen Therapeutics will participate in the 'Updates in Neuropsych' panel at the William Blair Biotech Focus Conference on July 15, 2021.

When is the William Blair Biotech Focus Conference 2021?

The William Blair Biotech Focus Conference 2021 is on July 15, 2021, at 9:00 a.m. PT.

How can I watch the VistaGen presentation at the conference?

The presentation can be viewed via a live webcast accessible through VistaGen's website.

What is the main focus of VistaGen's panel discussion?

The main focus is on updates regarding treatments for anxiety, depression, and other CNS disorders.

What stock symbol represents VistaGen Therapeutics?

VistaGen Therapeutics is represented by the stock symbol VTGN.

Vistagen Therapeutics, Inc.

NASDAQ:VTGN

VTGN Rankings

VTGN Latest News

VTGN Stock Data

62.65M
27.77M
0.25%
53.63%
1.54%
Biotechnology
Pharmaceutical Preparations
Link
United States of America
SOUTH SAN FRANCISCO